Table 3.
The Impact of Lung Function on All-Cause Mortality in the COPD and Non-COPD Population
Lung Function Indices | COPD | Non-COPD | |||||
---|---|---|---|---|---|---|---|
b | P | HR (95% CI) | b | P | HR (95% CI) | ||
FEV1% predicteda | 1 | 1.62 | <0.001 | 5.07 (2.67, 9.61) | 0.38 | 0.033 | 1.46 (1.03, 2.08) |
2 | 1.44 | <0.001 | 4.21 (2.22, 7.99) | 0.41 | 0.011 | 1.5 (1.1, 2.06) | |
3 | 0.8 | 0.016 | 2.23 (1.16, 4.3) | 0.18 | 0.236 | 1.2 (0.89, 1.61) | |
4 | 1.08 | <0.001 | 2.96 (1.57, 5.56) | Ref | Ref | 1 | |
5 | Ref | Ref | 1 | – | – | – | |
FVC% predictedb | 1 | 0.93 | <0.001 | 2.52 (1.55, 4.09) | 0.44 | 0.014 | 1.56 (1.1, 2.22) |
2 | 0.72 | 0.003 | 2.06 (1.28, 3.32) | 0.44 | 0.006 | 1.56 (1.14, 2.13) | |
3 | 0.26 | 0.332 | 1.3 (0.77, 2.19) | 0.32 | 0.039 | 1.37 (1.02, 1.86) | |
4 | Ref | Ref | 1 | Ref | Ref | 1 |
Notes: aFEV1% predicted in the COPD population: 1: < 60%, 2: 60% ~ 70%, 3: 70% ~ 80%, 4: 80% ~ 90%, 5: ≥ 90%; FEV1% predicted in the non-COPD population: 1: < 80%, 2: 80% ~ 90%, 3: 90% ~ 100%, 4: ≥ 100%. bFVC% predicted in the COPD and non-COPD populations: 1: < 80%, 2: 80% ~ 90%, 3: 90% ~ 100%, 4: ≥ 100%.